News 'Disagreement' Sees Europe’s Largest Trade Association Lose Its Chairman

‘Disagreement’ Sees Europe’s Largest Trade Association Lose Its Chairman



THE head of Europe’s largest trade association for the CBD industry is no longer in his post, it has emerged.

Mike Harlington has been Chairman of the UK-based Cannabis Trades Association (CTA) for four years, leading it through a period of rapid growth for the industry and helping boost member numbers to nearly 1,000.

But last night it emerged he is no longer employed by the CTA in that position, although there appears to be some uncertainty over his current employment status with the CTA.

Tom Whettem, founder of CBD firm British Cannabis and Compliance Director of the CTA, last night moved to reassure members it was ‘business as usual’ in a brief telephone conversation with BusinessCann.

Mike Harlington.

Statements To Be Released Next Week

BusinesCann understands there was a disagreement between the two senior board members earlier this week following the launch of Mr Whettem’s latest venture; Access CBD – a budget-priced CBD brand.

Mr Harlington is expected to make a public statement on these matters early next week. Mr Whettem declined to comment further, saying a statement was also imminent from the CTA.

This development will be viewed as significant for Europe’s largest CBD and cannabis trade association, as the deadline for the authorisation of CBD as a Novel Food approaches.

The CTA has repeatedly said it intends to mount a challenge to the Novel Food designation by way of an Article 4 challenge – effectively arguing that CBD has been consumed in hemp oil, in Europe, for hundreds of years – but this has yet be progressed.

They key tenet of this Article 4 position is that its members’ CBD products are derived from whole plant extracts – not isolates.

CTA members can pay anywhere between £50 and £900 a month for membership of an organisation which lobbies on their behalf and organises a number of successful trade shows.

@We will be updating this story as it develops over the coming days.

Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.


Please enter your comment!
Please enter your name here

Latest news

Not One Medicinal Cannabis Trial Launched By NHS Since Law Change

A LACK of clinical evidence is a key reason the National Health Service offers for the paucity of...

European Moves To Brand CBD A ‘Narcotic’ Are A Growing Threat To Industry

MOVES are underway in Brussels to the restrict the sale of CBD across Europe with questions being...

Market Round-Up; Branding Challenge – ‘What Gets Me High? Not ‘Who Makes It’. Organigram, Aurora, Lyphe Group et al

A THRIVING black market and cloying limits on sales and advertising are restricting cannabis brand recognition in...

UK CBD Pioneers To More Than Double Sales To Over £6m Following Canadian Takeover

CBD brand Love Hemp has been turbo-charged following its purchase by North American investors as it looks...


Legal UK Cannabis Industry Mapped Out For First Time – And Poised For Rapid Change

SOME say it's journalists who sketch history’s initial draft but this attempt to map-out the UK’s cannabis...

CBD Firms To Get Key Opportunity To Quiz FSA On Novel Food Compliance – For Free

THE European CBD industry is being given an opportunity to quiz UK regulators over the thorny issue...

Must read


You might also likeRELATED
Recommended to you